41 – 50 of 183
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Cancer Cell Radiobiological Studies Using In-House-Developed α-Particle Irradiator.
(
- Contribution to journal › Article
-
Mark
Intratherapeutic Biokinetic Measurements, Dosimetry Parameters Estimate, and Monitoring Treatment Efficacy using Cerenkov Luminescence Imaging in Preclinical Radionuclide Therapy.
(
- Contribution to journal › Article
-
Mark
Size-dependent lymphatic uptake of nanoscale-tailored particles as tumor mass increases
(
- Contribution to journal › Article
-
Mark
Superparamagnetic iron oxide nanoparticles as a multimodal contrast agent for up to five imaging modalities
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Radioimmunoimaging and Radioimmunotherapy of Prostate Cancer. Preclinical evaluation of kallikrein related peptidase 2 targeting
(
- Contribution to journal › Published meeting abstract
- 2014
-
Mark
Preclinical imaging of kallikrein-related peptidase 2 (hK2) in prostate cancer with a In-111-radiolabelled monoclonal antibody, 11B6
(
- Contribution to journal › Article
-
Mark
(68)Ga-labeled superparamagnetic iron oxide nanoparticles (SPIONs) for multi-modality PET/MR/Cherenkov luminescence imaging of sentinel lymph nodes.
(
- Contribution to journal › Article
-
Mark
Optimizing retention of multimodal imaging nanostructures in sentinel lymph nodes by nanoscale size tailoring.
(
- Contribution to journal › Article
-
Mark
Testis dosimetry in individual patients by combining a small-scale dosimetry model and pharmacokinetic modeling-application of (111)In-Ibritumomab Tiuxetan (Zevalin(®)).
(
- Contribution to journal › Article
-
Mark
A solid target system with remote handling of irradiated targets for PET cyclotrons.
(
- Contribution to journal › Article